Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China flag China · Delayed Price · Currency is CNY
10.97
+0.08 (0.73%)
Jul 11, 2025, 2:45 PM CST

SHA:603707 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
733.67826.14-189.451,0911,059806.12
Upgrade
Depreciation & Amortization
174.85174.85154.06139.5393.2284.55
Upgrade
Other Amortization
0.190.190.190.190.20.23
Upgrade
Loss (Gain) From Sale of Assets
0.040.040.040.111.030.22
Upgrade
Asset Writedown & Restructuring Costs
8.648.640.0310.227.2352
Upgrade
Loss (Gain) From Sale of Investments
-7.81-7.8185.58-24.1-24.57-10.55
Upgrade
Provision & Write-off of Bad Debts
8.228.22-3.05-0.423.22-
Upgrade
Other Operating Activities
20.87-34.841,241-99.4387.4755.67
Upgrade
Change in Accounts Receivable
-13.19-13.19163.36-1,456-148.2-345.27
Upgrade
Change in Inventory
598.72598.72213.28-731.57-444.05-1,223
Upgrade
Change in Accounts Payable
-185.77-185.77224.661,71046.8211.23
Upgrade
Change in Other Net Operating Assets
-20.08-20.08-21.25-15.113.4511.51
Upgrade
Operating Cash Flow
1,4641,5011,619595.45683.63-565.85
Upgrade
Operating Cash Flow Growth
-13.74%-7.28%171.92%-12.90%--
Upgrade
Capital Expenditures
-665.74-506.82-419.07-470.08-440.76-294.36
Upgrade
Sale of Property, Plant & Equipment
000.150.110.540.12
Upgrade
Cash Acquisitions
-0.72----13.87-
Upgrade
Investment in Securities
839.67-459.05-757.4736.06610.72-887.57
Upgrade
Other Investing Activities
66.5255.1414.3433.4213.519.03
Upgrade
Investing Cash Flow
239.73-910.73-1,162-400.5170.14-1,173
Upgrade
Short-Term Debt Issued
-----3,073
Upgrade
Long-Term Debt Issued
-1,8663,3993,3582,1261,266
Upgrade
Total Debt Issued
1,1091,8663,3993,3582,1264,339
Upgrade
Short-Term Debt Repaid
------2,311
Upgrade
Long-Term Debt Repaid
--2,373-3,094-3,441-2,687-
Upgrade
Total Debt Repaid
-2,711-2,373-3,094-3,441-2,687-2,311
Upgrade
Net Debt Issued (Repaid)
-1,601-506.04305.39-83.41-560.942,028
Upgrade
Issuance of Common Stock
0.54--0.3741.17227.35
Upgrade
Repurchase of Common Stock
-12.04-12.04-5.72-1.13-0.87-1.04
Upgrade
Common Dividends Paid
-212.3-213.19-248.47-226.65-191.75-261.21
Upgrade
Other Financing Activities
-----200-19.57
Upgrade
Financing Cash Flow
-1,825-731.2851.2-310.81-912.391,973
Upgrade
Foreign Exchange Rate Adjustments
-13.08-16.783.18-16.1120.05-9.88
Upgrade
Net Cash Flow
-133.98-157.49591.51-131.97-38.57224.78
Upgrade
Free Cash Flow
798.72994.411,200125.37242.87-860.21
Upgrade
Free Cash Flow Growth
-37.04%-17.14%857.27%-48.38%--
Upgrade
Free Cash Flow Margin
20.99%25.34%30.53%3.38%6.59%-29.51%
Upgrade
Free Cash Flow Per Share
0.480.600.760.080.15-0.54
Upgrade
Cash Income Tax Paid
-104.54108.8691.0146.06-5.82
Upgrade
Levered Free Cash Flow
386.81498.141,279-540.91-186.72-1,220
Upgrade
Unlevered Free Cash Flow
429.94545.431,330-504.75-129.08-1,184
Upgrade
Change in Net Working Capital
-319.95-209.93-1,801841.2560.571,563
Upgrade
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.